...
Dark
Light
Today: September 16, 2024
July 24, 2024
1 min read

QA Wolf secures $36M in Series B funding

TLDR:

  • QA Wolf, a test automation company based in Seattle, raised $36M in Series B funding led by Scale Venture Partners.
  • The company plans to use the funding to expand operations and development efforts, focusing on offering 100% parallelized regression tests for Android and iOS.

QA Wolf, a Seattle-based test automation company, recently announced that it has raised $36M in Series B funding. The funding round was led by Scale Venture Partners, with participation from Threshold Ventures and Ventureforgood, as well as existing investors Inspired Capital and Notation Capital. The company, led by CEO Jon Perl, aims to use the funds to expand operations and develop new infrastructure to offer 100% parallelized regression tests for Android and iOS.

QA Wolf is known for empowering software quality assurance with results-based end-to-end test automations. By aligning incentives with customer success and leveraging AI technology, the company is able to deliver comprehensive test coverage and accelerate software development cycles. Jon Perl, the CEO of QA Wolf, expressed his excitement about the new funding, stating that the company plans to make improvements to its existing infrastructure and become the only solution offering 100% parallelized regression tests for Android and iOS. He also mentioned that the ‘human-in-the-loop AI’ technology that enables 15-minute QA cycles for web apps will soon be extended to support the customer’s entire product stack.

This funding round signifies a significant milestone for QA Wolf, as it will allow the company to further enhance its services and meet the growing demand for efficient and effective test automation solutions. With the support of investors like Scale Venture Partners, QA Wolf is poised to remain at the forefront of the test automation industry and continue to drive innovation in the field.

Overall, the Series B funding for QA Wolf represents a major vote of confidence in the company’s vision and capabilities, as well as its potential for future growth and success in the competitive tech market.

Previous Story

Third Arc Bio secures $165M in Series A funding

Next Story

Biotech firm secures $18M in funding

Latest from Blog

Go toTop
Seraphinite AcceleratorBannerText_Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.